Tuesday, November 3, 2015

Prevalence of & Factors Associated with Rectal-Only Chlamydia & Gonorrhoea in Women & in Men Who Have Sex with Men

Both anorectal Chlamydia trachomatis (CT) and Neisseria gonorrhoea (NG) can occur as a rectal-only infection or concurrently with simultaneous urogenital infection with the same pathogen. Characterising the target groups in which rectal-only infections occur may improve the efficacy of screening practices.

We analysed data from two Dutch outpatient sexually transmitted infection (STI) clinics between 2011 and 2012. We included all men who have sex with men (MSM) (n = 9549) and women (n = 11113), ≥18 years, who had been tested for anorectal and urogenital CT and/or NG (either as a result of reporting anal sex/symptoms or via routine universal testing). Factors associated with rectal-only CT and NG infections were assessed using univariable and multivariable logistic regression.

In MSM, anorectal CT prevalence was 9.8% (693/7094), anorectal NG prevalence was 4.2% (397/9534). In women this was 9.5% overall (439/4597) and 0.9% (96/10972) respectively. Anorectal CT prevalence among women who were routinely universally tested was 10.4% (20/192), for selective testing this was 9.5% (419/4405) (p = 0.68). Anorectal NG infections were not detected among women who were routinely universally tested (p = 0.19). Among CT or NG positive MSM, rectal-only CT infections were found in 85.9% (595/693), for NG this was 85.6% (340/397) respectively. In positive women these figures were 22.1% (97/439)for CT and 20.8% (20/96) for NG, respectively. 

In MSM, independent factors associated with rectal-only CT were: being a sex worker, exclusively having sex with men, and absence of urogenital symptoms. In women, these factors were: older age and non-Western nationality. Factors associated with rectal-only NG in MSM were: having been warned for STIs by an (ex) partner, oropharyngeal NG infection, and absence of urogenital symptoms, while in women no significant factors were identified.

The prevalence of anorectal CT and NG was substantial in MSM and prevalence of anorectal CT was also substantial in women. Anorectal infections occurred mostly as rectal-only infections in MSM and mostly concurrent with other infections in women. Given the lack of useful indicators for rectal-only infections, selective screening based on a priori patient characteristics will have low discriminatory power both in relation to MSM and women.

Below:  Anatomic site distribution of CT or NG positive MSM and women both tested at urogenital and anorectal sites


Below:  Bubble plot depicting the factors univariably associated with anorectal CT and NG and rectal-only CT and NG in MSM and women including their relative share in the total number of anorectal CT and NG infections. The X-axis represents the odds ratio of anorectal CT or NG, the Y-axis represents the odds ratio of rectal-only CT or NG. The bubble represents the relative share in percentages of anorectal CT and NG infections per associated factor. The variable anal sex was not used for CT to prevent bias by testing indication.



Full article at: http://goo.gl/yJJ5Rk

  • 1Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service, Geleen, The Netherlands; Department of Medical Microbiology, School of Public Health and Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • 2Public Health Laboratory, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands; Department of Research, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands; STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands.
  • 3Department of Research, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands; STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands.
  • 4STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands; Department of Dermatology, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands; Centre for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, The Netherlands.  

No comments:

Post a Comment